Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CRNX

Crinetics Pharmaceuticals (CRNX)

Crinetics Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRNX
DateTimeSourceHeadlineSymbolCompany
19/07/202406:05GlobeNewswire Inc.Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:CRNXCrinetics Pharmaceuticals Inc
18/07/202407:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
18/07/202407:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
16/07/202406:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
16/07/202406:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
13/07/202406:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
11/07/202409:29GlobeNewswire Inc.Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CRNXCrinetics Pharmaceuticals Inc
11/07/202400:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
10/07/202408:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
19/06/202406:30GlobeNewswire Inc.EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024 Pacific Southwest Award WinnerNASDAQ:CRNXCrinetics Pharmaceuticals Inc
12/06/202406:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
12/06/202406:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
12/06/202406:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
12/06/202406:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
11/06/202406:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
11/06/202401:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
04/06/202406:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
31/05/202406:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
29/05/202403:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
22/05/202422:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
15/05/202408:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
11/05/202406:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
11/05/202402:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
10/05/202406:38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRNXCrinetics Pharmaceuticals Inc
10/05/202406:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
09/05/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
09/05/202406:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
12/03/202407:15Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
07/03/202412:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
07/03/202412:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CRNX

Your Recent History

Delayed Upgrade Clock